首页> 美国卫生研究院文献>Biomarkers in Cancer >Potential Biomarkers in the Sera of Breast Cancer Patients from Bahawalpur Pakistan
【2h】

Potential Biomarkers in the Sera of Breast Cancer Patients from Bahawalpur Pakistan

机译:巴基斯坦Bahawalpur乳腺癌患者血清中的潜在生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Most of the approximately 90,000 cases of Breast Cancer (BC) documented annually in Pakistan are not diagnosed properly because of lack of suitable markers. We performed serum proteome expression profiling of BC and benign breast disease (BBD) patients with the aim to identify biomarkers that can be helpful for diagnosis and prognosis of the disease. Sera of patients were analyzed by one-dimensional SDS polyacrylamide gel electrophoresis (PAGE). Differentially expressed proteins were subjected to identification through LC-MS/MS analysis. In majority of the BC cases some acute phase proteins (APP) and some complement system components (C3 and C8) containing fractions were up-regulated with the exception of transthyretin (TTR) which was predominantly (68.75%) down-regulated (n = 33/48) in the sera of these patients. Varying expression patterns were observed in BBD patients and healthy controls. These differentially expressed proteins have the potential to serve as diagnostic biomarkers for BC as well as benign breast diseases.
机译:由于缺乏合适的标记物,在巴基斯坦每年记录的大约90,000例乳腺癌(BC)病例中,大多数未被正确诊断。我们进行了BC和良性乳腺疾病(BBD)患者的血清蛋白质组表达分析,目的是鉴定有助于疾病诊断和预后的生物标志物。通过一维SDS聚丙烯酰胺凝胶电泳(PAGE)分析患者的血清。通过LC-MS / MS分析鉴定差异表达的蛋白质。在大多数BC病例中,某些急性期蛋白(APP)和某些补体系统组分(C3和C8)的组分被上调,而运甲状腺素蛋白(TTR)则主要被下调(68.75%)(n = 33/48)在这些患者的血清中。在BBD患者和健康对照组中观察到各种表达模式。这些差异表达的蛋白具有作为BC和良性乳腺疾病的诊断生物标志物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号